Cardiff Oncology Inc. buy melinda
Start price
22.06.17
/
50%
€76.61
Target price
19.12.17
€108.00
Performance (%)
-82.61%
End price
19.12.17
€13.32
Summary
This prediction ended on 19.12.17 with a price of €13.32. The BUY prediction by melinda for Cardiff Oncology Inc. performed very badly with a performance of -82.61%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | 5.578% | 5.578% | -29.987% | 93.149% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% | 68.627% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% | 116.238% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% | 56.217% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% | 70.924% |
Comments by melinda for this prediction
In the thread Trovagene diskutieren
Biopharma
* TrovaGene gibt Vereinbarung mit einem globalen biopharmazeutischen Unternehmen , die Tests und Dienstleistungen zu verwenden trova® ctDNS in der klinischen Krebsstudien
(Vom Mitglied beendet)
Stopped prediction by melinda for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.61
18.01.23
18.01.23
€2.00
18.01.24
18.01.24
-16.30%
19.01.24
19.01.24
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.84
05.04.19
05.04.19
€7.00
04.11.21
04.11.21
29.61%
05.11.21
05.11.21
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€76.61
22.06.17
22.06.17
€108.00
19.12.17
19.12.17
-82.61%
19.12.17
19.12.17
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€271.44
05.05.16
05.05.16
€324.00
19.05.16
19.05.16
31.03%
19.05.16
19.05.16